6
Participants
Start Date
May 31, 2007
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
Proton beam irradiation and ranibizumab
ranibizumab 0.5mg intravitreal monthly x 4, then prn combined with low dose proton beam irradiation 24Gy (2 fractions, 24 hours apart) during the first month of study.
Collaborators (1)
University of California, San Francisco
OTHER
Genentech, Inc.
INDUSTRY
University of California, Davis
OTHER